Associations of circulating levels of tryptophan-kynurenine metabolites and inflammation biomarker neopterin with overall survival among patients with stage I-III colorectal cancer

被引：0
|
作者：
Damerell, Victoria
van Roekel, Eline H.
Brezina, Stefanie
Kok, Dieuwertje E.
Lin, Tengda
Holthuijsen, Danielle D.
Ose, Jennifer
Himbert, Caroline
Eussen, Simone J. P.
Ulvik, Arve
van Duijnhoven, Franzel J.
Figueiredo, Jane C.
Li, Christopher I.
Siegel, Erin M.
Schneider, Martin
Shibata, David
Toriola, Adetunji A.
Ulrich, Alexis B.
Ueland, Per M.
Weijenberg, Matty P.
Gsur, Andrea
Kampman, Ellen
Ulrich, Cornelia M.
Gigic, Biljana
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3421
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3421
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Preoperative Cancer Inflammation Prognostic Index as a Superior Predictor of Short- and Long-Term Outcomes in Patients with Stage I-III Colorectal Cancer after Curative Surgery
    You, Jeng-Fu
    Hsu, Yu-Jen
    Chern, Yih-Jong
    Cheng, Ching-Chung
    Jong, Bor-Kang
    Liao, Chun-Kai
    Hsieh, Pao-Shiu
    Hsu, Hung-Chih
    Tsai, Wen-Sy
    CANCERS, 2022, 14 (24)
  • [42] Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer.
    Cohen, Stacey A.
    Kasi, Pashtoon Murtaza
    Aushev, Vasily N.
    Hanna, Diana L.
    Botta, Gregory P.
    Sharif, Saima
    Laliotis, Georgios I.
    Sharma, Vivek R.
    Alqahtani, Ali
    Chandana, Sreenivasa R.
    Kang, Sandra
    Chakrabarti, Sakti
    Somer, Bradley G.
    Kasi, Anup
    Dayyani, Farshid
    Malla, Midhun
    Jurdi, Adham A.
    Liu, Minetta C.
    Aleshin, Alexey
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 5 - 5
  • [43] Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component
    Zhu, Ziyu
    Cong, Xiliang
    Li, Rui
    Yin, Xin
    Li, Chunfeng
    Xue, Yingwei
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [44] C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients Reply
    Bekki, Tomoaki
    Shimomura, Manabu
    Yano, Takuya
    Akabane, Shintaro
    Hattori, Minoru
    Mochizuki, Tetsuya
    Ono, Kosuke
    Matsubara, Keiso
    Imaoka, Kouki
    Ishikawa, Sho
    Watanabe, Atsuhiro
    Sato, Saki
    Ohdan, Hideki
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (07) : 4248 - 4249
  • [45] Association between density of tumor infiltrating lymphocytes and disease-free survival (DFS) in patients with resected stage I-III colorectal cancer in the FACS randomized trial.
    Pugh, Sian Alexandra
    Moutasim, Karwan
    Jenkins, Nicholas Mark
    Shinkins, Bethany
    Thomas, Gareth
    Mant, David
    Primrose, John Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Serum cholinesterase combined with platelet-to-hemoglobin ratio for predicting survival prognosis in stage I-III colorectal cancer patients undergoing radical surgery: a retrospective cohort study
    Luyu Huang
    Kai Zhao
    Hongnan Lu
    Wei He
    Dazhuang Miao
    Yan Wang
    Bingcai Li
    Qi Wang
    Shixiong Jiang
    Yunhe Jia
    BMC Gastroenterology, 25 (1)
  • [47] Development and validation of nomograms based on pre-/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resection
    Dai, Xuan
    Li, Yifan
    Wang, Haoran
    Dai, Zhujiang
    Chen, Yuanyuan
    Liu, Yun
    Huang, Shiyong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [48] Real-World Treatment Patterns and Survival Among Patients with Stage I-III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment
    Seung, Soo Jin
    Moldaver, Daniel
    Hassan, Shazia
    Syed, Iqra
    Shanahan, Marykate
    Liu, Geoffrey
    ONCOLOGY AND THERAPY, 2024, 12 (02) : 311 - 326
  • [49] The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
    Marilena Petrera
    Laura Paleari
    Matteo Clavarezza
    Matteo Puntoni
    Silvia Caviglia
    Irene Maria Briata
    Massimo Oppezzi
    Eva Mihajlovic Mislej
    Borut Stabuc
    Michael Gnant
    Thomas Bachleitner-Hofmann
    Wilfried Roth
    Dominique Scherer
    Walter-E. Haefeli
    Cornelia M. Ulrich
    Andrea DeCensi
    BMC Cancer, 18
  • [50] The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2x2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
    Petrera, Marilena
    Paleari, Laura
    Clavarezza, Matteo
    Puntoni, Matteo
    Caviglia, Silvia
    Briata, Irene Maria
    Oppezzi, Massimo
    Mislej, Eva Mihajlovic
    Stabuc, Borut
    Gnant, Michael
    Bachleitner-Hofmann, Thomas
    Roth, Wilfried
    Scherer, Dominique
    Haefeli, Walter-E.
    Ulrich, Cornelia M.
    DeCensi, Andrea
    BMC CANCER, 2018, 18
12345